These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31210561

  • 21. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Moreira C, Ferreira MRA, Finger PF, Magalhães CG, Cunha CEP, Rodrigues RR, Otaka DY, Galvão CC, Salvarani FM, Moreira ÂN, Conceição FR.
    Vaccine; 2020 Mar 04; 38(11):2519-2526. PubMed ID: 32037222
    [Abstract] [Full Text] [Related]

  • 22. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.
    Front Immunol; 2024 Mar 04; 15():1469919. PubMed ID: 39315101
    [Abstract] [Full Text] [Related]

  • 23. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge.
    Kim NY, Ahn HB, Yu CH, Song DH, Hur GH, Shin YK, Shin S.
    Hum Vaccin Immunother; 2019 Mar 04; 15(2):412-419. PubMed ID: 30235058
    [Abstract] [Full Text] [Related]

  • 24. Subunit vaccine against the seven serotypes of botulism.
    Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT.
    Infect Immun; 2008 Mar 04; 76(3):1314-8. PubMed ID: 18070903
    [Abstract] [Full Text] [Related]

  • 25. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.
    J Infect Dis; 2016 May 15; 213(10):1606-14. PubMed ID: 26936913
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle.
    Moreira C, Ferreira MRA, da Cunha CEP, Donassolo RA, Finger PF, Moreira GMSG, Otaka DY, de Sousa LA, Barbosa JD, Moreira ÂN, Salvarani FM, Conceição FR.
    Toxins (Basel); 2018 Sep 20; 10(10):. PubMed ID: 30241350
    [Abstract] [Full Text] [Related]

  • 27. What next for botulism vaccine development?
    Webb RP, Smith LA.
    Expert Rev Vaccines; 2013 May 20; 12(5):481-92. PubMed ID: 23659297
    [Abstract] [Full Text] [Related]

  • 28. Oral vaccination with an adenovirus-vectored vaccine protects against botulism.
    Chen S, Xu Q, Zeng M.
    Vaccine; 2013 Feb 04; 31(7):1009-11. PubMed ID: 23295065
    [Abstract] [Full Text] [Related]

  • 29. Development of an Equine Antitoxin by Immunizing the Halla Horse with the Receptor-Binding Domain of Botulinum Neurotoxin Type A1.
    Kim NY, Park KE, Lee YJ, Kim YM, Hong SH, Son WR, Hong S, Lee S, Ahn HB, Yang J, Seo JP, Lim YK, Yu CH, Hur GH, Jeong ST, Lee HS, Song K, Kang TJ, Shin YK, Choi JS, Choi JY.
    J Microbiol Biotechnol; 2019 Jul 28; 29(7):1165-1176. PubMed ID: 31280529
    [Abstract] [Full Text] [Related]

  • 30. Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.
    Shone C, Agostini H, Clancy J, Gu M, Yang HH, Chu Y, Johnson V, Taal M, McGlashan J, Brehm J, Tong X.
    Infect Immun; 2009 Jul 28; 77(7):2795-801. PubMed ID: 19398544
    [Abstract] [Full Text] [Related]

  • 31. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.
    Ruwona TB, Xu H, Li J, Diaz-Arévalo D, Kumar A, Zeng M, Cui Z.
    Hum Vaccin Immunother; 2016 May 03; 12(5):1188-92. PubMed ID: 26837242
    [Abstract] [Full Text] [Related]

  • 32. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
    Yu YZ, Li N, Zhu HQ, Wang RL, Du Y, Wang S, Yu WY, Sun ZW.
    Vaccine; 2009 May 11; 27(21):2816-22. PubMed ID: 19428892
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.
    Zichel R, Mimran A, Keren A, Barnea A, Steinberger-Levy I, Marcus D, Turgeman A, Reuveny S.
    Clin Vaccine Immunol; 2010 May 11; 17(5):784-92. PubMed ID: 20357058
    [Abstract] [Full Text] [Related]

  • 35. Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate.
    Ben David A, Torgeman A, Barnea A, Zichel R.
    Protein Expr Purif; 2015 Jun 11; 110():122-9. PubMed ID: 25727047
    [Abstract] [Full Text] [Related]

  • 36. Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D.
    Otaka DY, Barbosa JD, Moreira C, Ferreira MRA, Cunha CEP, Brito ARS, Donassolo RA, Moreira ÂN, Conceição FR, Salvarani FM.
    Toxins (Basel); 2017 Sep 22; 9(10):. PubMed ID: 28937601
    [Abstract] [Full Text] [Related]

  • 37. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z.
    Vaccine; 2009 Oct 19; 27(44):6148-53. PubMed ID: 19712769
    [Abstract] [Full Text] [Related]

  • 38. Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.
    Rasetti-Escargueil C, Popoff MR.
    Toxins (Basel); 2019 Sep 12; 11(9):. PubMed ID: 31547338
    [Abstract] [Full Text] [Related]

  • 39. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.
    Byrne MP, Smith TJ, Montgomery VA, Smith LA.
    Infect Immun; 1998 Oct 12; 66(10):4817-22. PubMed ID: 9746584
    [Abstract] [Full Text] [Related]

  • 40. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.
    Valipour E, Moosavi ML, Amani J, Nazarian S.
    World J Microbiol Biotechnol; 2014 Jun 12; 30(6):1861-7. PubMed ID: 24469548
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.